Taveras; Arthur G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Taveras; Arthur G..The latest application filed is for "bicyclic aryl sphingosine 1-phosphate analogs".

Company Profile

1.52.52

Taveras; Arthur G. - Boston MA
Taveras; Arthur G. - Cambridge MA
Taveras; Arthur G. - Southborough MA US
Taveras; Arthur G. - Denville NJ
Taveras, Arthur G. - Rockaway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20190209592 - Thomas; Jermaine ; et al.	2019-07-11
Bicyclic aryl sphingosine 1-phosphate analogs Grant 10,166,250 - Thomas , et al. J	2019-01-01
Heterobicyclic sphingosine 1-phosphate analogs Grant 10,081,646 - Caldwell , et al. September 25, 2	2018-09-25
Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20180133233 - Thomas; Jermaine ; et al.	2018-05-17
Compounds that are S1P modulating agents and/or ATX modulating agents Grant 9,944,666 - Guckian , et al. April 17, 2	2018-04-17
Heterobicyclic Sphingosine 1-phosphate Analogs App 20180002356 - Caldwell; Richard D. ; et al.	2018-01-04
S1P and/or ATX modulating agents Grant 9,850,206 - Peng , et al. December 26, 2	2017-12-26
Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,827,258 - Thomas , et al. November 28, 2	2017-11-28
S1P and/or ATX modulating agents Grant 9,771,326 - Peng , et al. September 26, 2	2017-09-26
Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20170239280 - Thomas; Jermaine ; et al.	2017-08-24
Heterobicyclic sphingosine 1-phosphate analogs Grant 9,708,353 - Caldwell , et al. July 18, 2	2017-07-18
Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents App 20170174710 - Guckian; Kevin M. ; et al.	2017-06-22
Atx Modulating Agents App 20170158687 - Guckian; Kevin M. ; et al.	2017-06-08
Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,572,824 - Thomas , et al. February 21, 2	2017-02-21
Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20160129023 - Thomas; Jermaine ; et al.	2016-05-12
Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,186,367 - Thomas , et al. November 17, 2	2015-11-17
Heterobicyclic sphingosine 1-phosphate analogs Grant 9,181,191 - Caldwell , et al. November 10, 2	2015-11-10
S1p And/or Atx Modulating Agents App 20150299123 - Peng; Hairuo ; et al.	2015-10-22
S1p And/or Atx Modulating Agents App 20150274663 - Peng; Hairuo ; et al.	2015-10-01
Heterobicyclic Sphingosine 1-phosphate Analogs App 20150232492 - Caldwell; Richard D. ; et al.	2015-08-20
Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20140309190 - Thomas; Jermaine ; et al.	2014-10-16
Heterobicyclic metalloprotease inhibitors Grant 8,835,441 - Steeneck , et al. September 16, 2	2014-09-16
Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,802,659 - Thomas , et al. August 12, 2	2014-08-12
Heterobicyclic sphingosine 1-phosphate analogs App 20140100195 - Caldwell; Richard D. ; et al.	2014-04-10
Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,546,359 - Caldwell , et al. October 1, 2	2013-10-01
Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20130059821 - Caldwell; Richard D. ; et al.	2013-03-07
Heterobicyclic sphingosine 1-phosphate analogs Grant 8,349,849 - Caldwell , et al. January 8, 2	2013-01-08
Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,269,043 - Caldwell , et al. September 18, 2	2012-09-18
Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20120190649 - Thomas; Jermaine ; et al.	2012-07-26
Crystalline polymorphs of a CXC-chemokine receptor ligand Grant 8,207,221 - Hu , et al. June 26, 2	2012-06-26
Heterobicyclic Metalloprotease Inhibitors App 20120015920 - Steeneck; Christoph ; et al.	2012-01-19
Dipeptidyl peptidase-IV inhibitors Grant 8,076,330 - Kroth , et al. December 13, 2	2011-12-13
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands App 20110213029 - Taveras; Arthur G. ; et al.	2011-09-01
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,964,646 - Taveras , et al. June 21, 2	2011-06-21
Treatment of chemokine mediated diseases Grant 7,960,433 - Taveras , et al. June 14, 2	2011-06-14
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,947,720 - Taveras , et al. May 24, 2	2011-05-24
Heterobicyclic metalloprotease inhibitors Grant 7,795,245 - Steeneck , et al. September 14, 2	2010-09-14
Thiadiazoles as CXC- and CC- chemokine receptor ligands Grant 7,786,149 - Biju , et al. August 31, 2	2010-08-31
Bicyclic aryl sphingosine 1-phosphate analogs App 20100160258 - Caldwell; Richard D. ; et al.	2010-06-24
Heterobicyclic sphingosine 1-phosphate analogs App 20100160357 - Caldwell; Richard D. ; et al.	2010-06-24
Heterotricyclic Metalloprotease Inhibitors App 20100087420 - Gege; Christian ; et al.	2010-04-08
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands Grant 7,691,856 - Taveras , et al. April 6, 2	2010-04-06
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands Grant 7,671,212 - Taveras , et al. March 2, 2	2010-03-02
Heterobicyclic Metalloprotease Inhibitors App 20090312312 - STEENECK; Christoph ; et al.	2009-12-17
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands App 20090306079 - Taveras; Arthur G. ; et al.	2009-12-10
Heterobicyclic metalloprotease inhibitors App 20080161300 - Steeneck; Christoph ; et al.	2008-07-03
Thiadiazoles As Cxc- And Cc- Chemokine Receptor Ligands App 20080090823 - Biju; Purakkattle J. ; et al.	2008-04-17
Thiadiazoles AS CXC- and CC- chemokine receptor ligands Grant 7,338,968 - Biju , et al. March 4, 2	2008-03-04
CXCR1 and CXCR2 chemokine antagonists Grant 7,326,729 - Chao , et al. February 5, 2	2008-02-05
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands App 20070264230 - Taveras; Arthur G. ; et al.	2007-11-15
Cxcr1 And Cxcr2 Chemokine Antagonists App 20070248594 - Chao; Jianhua ; et al.	2007-10-25
Heterobicyclic metalloprotease inhibitors App 20070155738 - Steeneck; Christoph ; et al.	2007-07-05
Treatment of chemokine mediated diseases App 20070155756 - Taveras; Arthur G. ; et al.	2007-07-05
Heterobicyclic metalloprotease inhibitors App 20070155737 - Gallagher; Brian M. JR. ; et al.	2007-07-05
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20070021494 - Taveras; Arthur G. ; et al.	2007-01-25
Heterobicyclic metalloprotease inhibitors App 20060293345 - Steeneck; Christoph ; et al.	2006-12-28
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,132,445 - Taveras , et al. November 7, 2	2006-11-07
Thiadiazoles AS CXC- and CC- chemokine receptor ligands App 20060223864 - Biju; Purakkattle J. ; et al.	2006-10-05
Multicyclic bis-amide MMP inhibitors App 20060173183 - Powers; Timothy ; et al.	2006-08-03
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands App 20060025453 - Taveras; Arthur G. ; et al.	2006-02-02
CXCR1 and CXCR2 chemokine antagonists App 20060014794 - Chao; Jianhua ; et al.	2006-01-19
3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists Grant 6,903,131 - Taveras , et al. June 7, 2	2005-06-07
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists Grant 6,878,709 - Taveras , et al. April 12, 2	2005-04-12
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists App 20040235908 - Taveras, Arthur G. ; et al.	2004-11-25
Farnesyl protein transferase inhibitors Grant 6,800,636 - Guzi , et al. October 5, 2	2004-10-05
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands App 20040186142 - Taveras, Arthur G. ; et al.	2004-09-23
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040147559 - Taveras, Arthur G. ; et al.	2004-07-29
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040106794 - Taveras, Arthur G. ; et al.	2004-06-03
Farnesyl protein transferase inhibitors Grant 6,740,661 - Taveras , et al. May 25, 2	2004-05-25
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040097547 - Taveras, Arthur G. ; et al.	2004-05-20
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists App 20040063709 - Taveras, Arthur G. ; et al.	2004-04-01
Treatment of chemokine mediated diseases App 20040053953 - Taveras, Arthur G. ; et al.	2004-03-18
3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists App 20040034229 - Taveras, Arthur G. ; et al.	2004-02-19
3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists App 20030204085 - Taveras, Arthur G. ; et al.	2003-10-30
3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists App 20030097004 - Taveras, Arthur G. ; et al.	2003-05-22
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases App 20030055065 - Bishop, W. Robert ; et al.	2003-03-20
Farnesyl protein transferase inhibitors App 20030040520 - Guzi, Timothy ; et al.	2003-02-27
Farnesyl protein transferase inhibitors App 20020103207 - Taveras, Arthur G. ; et al.	2002-08-01
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases App 20020068742 - Bishop, W. Robert ; et al.	2002-06-06
Compounds useful for inhibition of farnesyl protein transferase Grant 6,387,905 - Njoroge , et al. May 14, 2	2002-05-14
Farnesyl protein transferase inhibitors Grant 6,372,747 - Taveras , et al. April 16, 2	2002-04-16
Farnesyl protein transferase inhibitors Grant 6,362,188 - Guzi , et al. March 26, 2	2002-03-26
Compounds useful for inhibition of farnesyl protein transferase App 20020019400 - Njoroje, FGeorge ; et al.	2002-02-14
Compounds useful for inhibition of farnesyl protein transferase Grant 6,228,856 - Njoroge , et al. May 8, 2	2001-05-08
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 6,143,758 - Doll , et al. November 7, 2	2000-11-07
Compounds useful for inhibition of farnesyl protein transferase Grant 6,124,295 - Taveras , et al. September 26, 2	2000-09-26
Tricyclic compounds useful as FPT inhibitors Grant 6,071,907 - Njoroge , et al. June 6, 2	2000-06-06
Compounds useful for inhibition of farnesyl protein transferase Grant 6,040,305 - Taveras , et al. March 21, 2	2000-03-21
Compounds useful for inhibition of farnesyl protein transferase Grant 6,030,982 - Njoroge , et al. February 29, 2	2000-02-29
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,958,890 - Rane , et al. September 28, 1	1999-09-28
Tricyclic compounds useful as inhibitors of farnesyl-protein transferase Grant 5,958,940 - Rane , et al. September 28, 1	1999-09-28
Compounds useful for inhibition of farnesyl protein transferase Grant 5,945,429 - Taveras , et al. August 31, 1	1999-08-31
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease Grant 5,874,442 - Doll , et al. February 23, 1	1999-02-23
Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases Grant 5,807,853 - Bishop , et al. September 15, 1	1998-09-15
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,728,703 - Bishop , et al. March 17, 1	1998-03-17
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,721,236 - Bishop , et al. February 24, 1	1998-02-24
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases Grant 5,719,148 - Bishop , et al. February 17, 1	1998-02-17
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,696,121 - Bishop , et al. December 9, 1	1997-12-09